{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:48:58Z","timestamp":1791640138928,"version":"4.3.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["897828"],"award-info":[{"award-number":["897828"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM107000"],"award-info":[{"award-number":["T32GM107000"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM122597, R01HD091357, R01HD094788"],"award-info":[{"award-number":["R35GM122597, R01HD091357, R01HD094788"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum. Genet."],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>XIST RNA is heavily studied for its role in fundamental epigenetics and X-chromosome inactivation; however, the translational potential of this singular RNA has been much less explored. This article combines elements of a review on XIST biology with our perspective on the translational prospects and challenges of XIST transgenics. We first briefly review aspects of XIST RNA basic biology that are key to its translational relevance, and then discuss recent efforts to develop translational utility of XIST for chromosome dosage disorders, particularly Down syndrome (DS). Remarkably, it was shown\u00a0in vitro\u00a0that expression of an XIST transgene inserted into one chromosome 21 can comprehensively silence that chromosome and \u201cdosage compensate\u201d Trisomy 21, the cause of DS. Here we summarize recent findings and discuss potential paths whereby ability to induce \u201ctrisomy silencing\u201d can advance translational research for new therapeutic strategies. Despite its common nature, the underlying biology for various aspects of DS, including cell types and pathways impacted (and when), is poorly understood. Recent studies show that an inducible iPSC system to dosage-correct chromosome 21 can provide a powerful approach to unravel the cells and pathways\u00a0<jats:italic>directly<\/jats:italic>\u00a0impacted, and the developmental timing, information key to design pharmacotherapeutics. In addition, we discuss prospects of a more far-reaching and challenging possibility that XIST itself could be developed into a therapeutic agent, for targeted cellular \u201cchromosome therapy\u201d. A few rare case studies of imbalanced X;autosome translocations indicate that natural XIST can rescue an otherwise lethal trisomy. The potential efficacy of XIST transgenes later in development faces substantial biological and technical challenges, although recent findings are encouraging, and technology is rapidly evolving. Hence, it is compelling to consider the transformative possibility that XIST-mediated chromosome therapy may ultimately be developed, for specific pathologies seen in DS, or other duplication disorders.<\/jats:p>","DOI":"10.1007\/s00439-024-02651-8","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T03:01:25Z","timestamp":1709953285000},"page":"843-855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Trisomy silencing by XIST: translational prospects and challenges"],"prefix":"10.1007","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0223-3364","authenticated-orcid":false,"given":"Khusali","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan T.","family":"Czerminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6572-3128","authenticated-orcid":false,"given":"Jeanne B.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,9]]},"reference":[{"key":"2651_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ajmg.1320020304","volume":"2","author":"PW Allderdice","year":"1978","unstructured":"Allderdice PW, Miller OJ, Miller DA, Klinger HP (1978) Spreading of inactivation in an (X;14) translocation. Am J Med Genet 2:233\u2013240. https:\/\/doi.org\/10.1002\/ajmg.1320020304","journal-title":"Am J Med Genet"},{"key":"2651_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","volume":"6","author":"SE Antonarakis","year":"2020","unstructured":"Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, Sherman SL, Reeves RH (2020) Down Syndrome. Nat Rev Dis Primers 6:9. https:\/\/doi.org\/10.1038\/s41572-019-0143-7","journal-title":"Nat Rev Dis Primers"},{"key":"2651_CR3","doi-asserted-by":"publisher","first-page":"R242","DOI":"10.1093\/hmg\/ddy148","volume":"27","author":"BP Balaton","year":"2018","unstructured":"Balaton BP, Dixon-McDougall T, Peeters SB, Brown CJ (2018) The eXceptional nature of the X chromosome. Hum Mol Genet 27:R242\u2013R249. https:\/\/doi.org\/10.1093\/hmg\/ddy148","journal-title":"Hum Mol Genet"},{"key":"2651_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/2022.05.11.491519","author":"P Bansal","year":"2023","unstructured":"Bansal P, Banda EC, Glatt-Deeley HR, Stoddard CE, Linsley JW, Arora N, Ahern DT, Kondaveeti Y, Nicouleau M, Sabariego-Navarro M, Dierssen M, Finkbeiner S, Pinter SF (2023) A dynamic in vitro model of Down Syndrome neurogenesis with Trisomy 21 gene dosage correction. bioRxiv. https:\/\/doi.org\/10.1101\/2022.05.11.491519","journal-title":"bioRxiv"},{"key":"2651_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1515\/revneuro-2022-0067","volume":"34","author":"R Bartesaghi","year":"2023","unstructured":"Bartesaghi R (2023) Brain circuit pathology in Down syndrome: from neurons to neural networks. Rev Neurosci 34:365\u2013423. https:\/\/doi.org\/10.1515\/revneuro-2022-0067","journal-title":"Rev Neurosci"},{"key":"2651_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ceb.2020.11.004","volume":"70","author":"J Boeren","year":"2021","unstructured":"Boeren J, Gribnau J (2021) Xist-mediated chromatin changes that establish silencing of an entire X chromosome in mammals. Curr Opin Cell Biol 70:44\u201350. https:\/\/doi.org\/10.1016\/j.ceb.2020.11.004","journal-title":"Curr Opin Cell Biol"},{"key":"2651_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1101\/gad.337196.120","volume":"34","author":"N Brockdorff","year":"2020","unstructured":"Brockdorff N, Bowness JS, Wei G (2020) Progress toward understanding chromosome silencing by Xist RNA. Genes Dev 34:733\u2013744. https:\/\/doi.org\/10.1101\/gad.337196.120","journal-title":"Genes Dev"},{"key":"2651_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/368154a0","volume":"368","author":"CJ Brown","year":"1994","unstructured":"Brown CJ, Willard HF (1994) The human X-inactivation centre is not required for maintenance of X-chromosome inactivation. Nature 368:154\u2013156. https:\/\/doi.org\/10.1038\/368154a0","journal-title":"Nature"},{"key":"2651_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0092-8674(92)90520-m","volume":"71","author":"CJ Brown","year":"1992","unstructured":"Brown CJ, Hendrich BD, Rupert JL, Lafreniere RG, Xing Y, Lawrence J, Willard HF (1992) The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 71:527\u2013542. https:\/\/doi.org\/10.1016\/0092-8674(92)90520-m","journal-title":"Cell"},{"key":"2651_CR10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nn1726","volume":"9","author":"I Bystron","year":"2006","unstructured":"Bystron I, Rakic P, Molnar Z, Blakemore C (2006) The first neurons of the human cerebral cortex. Nat Neurosci 9:880\u2013886. https:\/\/doi.org\/10.1038\/nn1726","journal-title":"Nat Neurosci"},{"key":"2651_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","volume":"24","author":"PJ Chen","year":"2023","unstructured":"Chen PJ, Liu DR (2023) Prime editing for precise and highly versatile genome manipulation. Nat Rev Genet 24:161\u2013177. https:\/\/doi.org\/10.1038\/s41576-022-00541-1","journal-title":"Nat Rev Genet"},{"key":"2651_CR12","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1038\/s41467-018-07630-y","volume":"9","author":"JC Chiang","year":"2018","unstructured":"Chiang JC, Jiang J, Newburger PE, Lawrence JB (2018) Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro. Nat Commun 9:5180. https:\/\/doi.org\/10.1038\/s41467-018-07630-y","journal-title":"Nat Commun"},{"key":"2651_CR13","doi-asserted-by":"publisher","first-page":"10104","DOI":"10.1073\/pnas.0610946104","volume":"104","author":"JC Chow","year":"2007","unstructured":"Chow JC, Hall LL, Baldry SE, Thorogood NP, Lawrence JB, Brown CJ (2007) Inducible XIST-dependent X-chromosome inactivation in human somatic cells is reversible. Proc Natl Acad Sci U S A 104:10104\u201310109. https:\/\/doi.org\/10.1073\/pnas.0610946104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2651_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1083\/jcb.132.3.259","volume":"132","author":"CM Clemson","year":"1996","unstructured":"Clemson CM, McNeil JA, Willard HF, Lawrence JB (1996) XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear\/chromosome structure. J Cell Biol 132:259\u2013275. https:\/\/doi.org\/10.1083\/jcb.132.3.259","journal-title":"J Cell Biol"},{"issue":"21\u201332","key":"2651_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2020.05.021","volume":"54","author":"D Colognori","year":"2020","unstructured":"Colognori D, Sunwoo H, Wang D, Wang CY, Lee JT (2020) Xist repeats A and B account for two distinct phases of X inactivation establishment. Dev Cell 54(21\u201332):e5. https:\/\/doi.org\/10.1016\/j.devcel.2020.05.021","journal-title":"Dev Cell"},{"key":"2651_CR16","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/hmg\/ddt513","volume":"23","author":"AM Cotton","year":"2014","unstructured":"Cotton AM, Chen CY, Lam LL, Wasserman WW, Kobor MS, Brown CJ (2014) Spread of X-chromosome inactivation into autosomal sequences: role for DNA elements, chromatin features and chromosomal domains. Hum Mol Genet 23:1211\u20131223. https:\/\/doi.org\/10.1093\/hmg\/ddt513","journal-title":"Hum Mol Genet"},{"key":"2651_CR17","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0360","author":"KM Creamer","year":"2017","unstructured":"Creamer KM, Lawrence JB (2017) XIST RNA: a window into the broader role of RNA in nuclear chromosome architecture. Philos Trans R Soc Lond B Biol Sci. https:\/\/doi.org\/10.1098\/rstb.2016.0360","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"3509\u20133525","key":"2651_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.07.004","volume":"81","author":"KM Creamer","year":"2021","unstructured":"Creamer KM, Kolpa HJ, Lawrence JB (2021) Nascent RNA scaffolds contribute to chromosome territory architecture and counter chromatin compaction. Mol Cell 81(3509\u20133525):e5. https:\/\/doi.org\/10.1016\/j.molcel.2021.07.004","journal-title":"Mol Cell"},{"key":"2651_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1083\/jcb.153.4.773","volume":"153","author":"G Csankovszki","year":"2001","unstructured":"Csankovszki G, Nagy A, Jaenisch R (2001) Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. J Cell Biol 153:773\u2013784. https:\/\/doi.org\/10.1083\/jcb.153.4.773","journal-title":"J Cell Biol"},{"issue":"294\u2013308","key":"2651_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2019.12.015","volume":"52","author":"JT Czerminski","year":"2020","unstructured":"Czerminski JT, Lawrence JB (2020) Silencing trisomy 21 with XIST in neural stem cells promotes neuronal differentiation. Dev Cell 52(294\u2013308):e3. https:\/\/doi.org\/10.1016\/j.devcel.2019.12.015","journal-title":"Dev Cell"},{"key":"2651_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.972201","volume":"16","author":"JT Czerminski","year":"2022","unstructured":"Czerminski JT, King OD, Lawrence JB (2022) Large-scale organoid study suggests effects of trisomy 21 on early fetal neurodevelopment are more subtle than variability between isogenic lines and experiments. Front Neurosci 16:972201. https:\/\/doi.org\/10.3389\/fnins.2022.972201","journal-title":"Front Neurosci"},{"key":"2651_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.58","volume":"5","author":"WJ Dai","year":"2016","unstructured":"Dai WJ, Zhu LY, Yan ZY, Xu Y, Wang QL, Lu XJ (2016) CRISPR-Cas9 for in vivo Gene therapy: promise and hurdles. Mol Ther Nucleic Acids 5:e349. https:\/\/doi.org\/10.1038\/mtna.2016.58","journal-title":"Mol Ther Nucleic Acids"},{"key":"2651_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005983","author":"I Das","year":"2013","unstructured":"Das I, Park JM, Shin JH, Jeon SK, Lorenzi H, Linden DJ, Worley PF, Reeves RH (2013) Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.3005983","journal-title":"Sci Transl Med"},{"key":"2651_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164144","author":"CPM de Castro","year":"2021","unstructured":"de Castro CPM, Cadefau M, Cuartero S (2021) The mutational landscape of myeloid leukaemia in Down syndrome. Cancers (basel). https:\/\/doi.org\/10.3390\/cancers13164144","journal-title":"Cancers (basel)"},{"key":"2651_CR25","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1089\/crispr.2022.0051","volume":"5","author":"S Demirci","year":"2022","unstructured":"Demirci S, Essawi K, Germino-Watnick P, Liu X, Hakami W, Tisdale JF (2022) Advances in CRISPR delivery methods: perspectives and challenges. CRISPR J 5:660\u2013676. https:\/\/doi.org\/10.1089\/crispr.2022.0051","journal-title":"CRISPR J"},{"key":"2651_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13072-022-00438-7","volume":"15","author":"T Dixon-McDougall","year":"2022","unstructured":"Dixon-McDougall T, Brown CJ (2022) Multiple distinct domains of human XIST are required to coordinate gene silencing and subsequent heterochromatin formation. Epigenetics Chromatin 15:6. https:\/\/doi.org\/10.1186\/s13072-022-00438-7","journal-title":"Epigenetics Chromatin"},{"key":"2651_CR27","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","volume":"20","author":"J Fortea","year":"2021","unstructured":"Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M (2021) Alzheimer\u2019s disease associated with Down syndrome: a genetic form of dementia. Lancet Neurol 20:930\u2013942. https:\/\/doi.org\/10.1016\/S1474-4422(21)00245-3","journal-title":"Lancet Neurol"},{"key":"2651_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cbpa.2020.04.020","volume":"57","author":"RAF Gjaltema","year":"2020","unstructured":"Gjaltema RAF, Rots MG (2020) Advances of epigenetic editing. Curr Opin Chem Biol 57:75\u201381. https:\/\/doi.org\/10.1016\/j.cbpa.2020.04.020","journal-title":"Curr Opin Chem Biol"},{"key":"2651_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/bs.pbr.2016.11.003","volume":"230","author":"G Gowing","year":"2017","unstructured":"Gowing G, Svendsen S, Svendsen CN (2017) Ex vivo gene therapy for the treatment of neurological disorders. Prog Brain Res 230:99\u2013132. https:\/\/doi.org\/10.1016\/bs.pbr.2016.11.003","journal-title":"Prog Brain Res"},{"key":"2651_CR30","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.tig.2022.01.007","volume":"38","author":"NB Grimm","year":"2022","unstructured":"Grimm NB, Lee JT (2022) Selective Xi reactivation and alternative methods to restore MECP2 function in Rett syndrome. Trends Genet 38:920\u2013943. https:\/\/doi.org\/10.1016\/j.tig.2022.01.007","journal-title":"Trends Genet"},{"key":"2651_CR31","doi-asserted-by":"publisher","first-page":"8677","DOI":"10.1073\/pnas.132468999","volume":"99","author":"LL Hall","year":"2002","unstructured":"Hall LL, Byron M, Sakai K, Carrel L, Willard HF, Lawrence JB (2002) An ectopic human XIST gene can induce chromosome inactivation in postdifferentiation human HT-1080 cells. Proc Natl Acad Sci U S A 99:8677\u20138682. https:\/\/doi.org\/10.1073\/pnas.132468999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2651_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3233\/trd-200090","volume":"5","author":"JA Hendrix","year":"2021","unstructured":"Hendrix JA, Amon A, Abbeduto L, Agiovlasitis S, Alsaied T, Anderson HA, Bain LJ, Baumer N, Bhattacharyya A, Bogunovic D, Botteron KN, Capone G, Chandan P, Chase I, Chicoine B, Cieuta-Walti C, DeRuisseau LR, Durand S, Esbensen A, Fortea J, Gimenez S, Granholm AC, Hahn LJ, Head E, Hillerstrom H, Jacola LM, Janicki MP, Jasien JM, Kamer AR, Kent RD, Khor B, Lawrence JB, Lemonnier C, Lewanda AF, Mobley W, Moore PE, Nelson LP, Oreskovic NM, Osorio RS, Patterson D, Rasmussen SA, Reeves RH, Roizen N, Santoro S, Sherman SL, Talib N, Tapia IE, Walsh KM, Warren SF, White AN, Wong GW, Yi JS (2021) Opportunities, barriers, and recommendations in down syndrome research. Transl Sci Rare Dis 5:99\u2013129. https:\/\/doi.org\/10.3233\/trd-200090","journal-title":"Transl Sci Rare Dis"},{"key":"2651_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1242\/dev.026427","volume":"136","author":"Y Hoki","year":"2009","unstructured":"Hoki Y, Kimura N, Kanbayashi M, Amakawa Y, Ohhata T, Sasaki H, Sado T (2009) A proximal conserved repeat in the Xist gene is essential as a genomic element for X-inactivation in mouse. Development 136:139\u2013146. https:\/\/doi.org\/10.1242\/dev.026427","journal-title":"Development"},{"key":"2651_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-genom-083117-021632","volume":"19","author":"L Holtzman","year":"2018","unstructured":"Holtzman L, Gersbach CA (2018) Editing the epigenome: reshaping the genomic landscape. Annu Rev Genom Hum Genet 19:43\u201371. https:\/\/doi.org\/10.1146\/annurev-genom-083117-021632","journal-title":"Annu Rev Genom Hum Genet"},{"key":"2651_CR35","first-page":"179","volume-title":"Genetic disorders and the fetus: diagnosis, prevention, and treatment","author":"L Hsu","year":"1992","unstructured":"Hsu L (1992) Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Milunsky A (ed) Genetic disorders and the fetus: diagnosis, prevention, and treatment, 3rd edn. Johns Hopkins University Press, Baltimore, pp 179\u2013248","edition":"3"},{"key":"2651_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2022.101927","volume":"75","author":"EC Jacobson","year":"2022","unstructured":"Jacobson EC, Pandya-Jones A, Plath K (2022) A lifelong duty: how Xist maintains the inactive X chromosome. Curr Opin Genet Dev 75:101927. https:\/\/doi.org\/10.1016\/j.gde.2022.101927","journal-title":"Curr Opin Genet Dev"},{"key":"2651_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nature12394","volume":"500","author":"J Jiang","year":"2013","unstructured":"Jiang J, Jing Y, Cost GJ, Chiang JC, Kolpa HJ, Cotton AM, Carone DM, Carone BR, Shivak DA, Guschin DY, Pearl JR, Rebar EJ, Byron M, Gregory PD, Brown CJ, Urnov FD, Hall LL, Lawrence JB (2013) Translating dosage compensation to trisomy 21. Nature 500:296\u2013300. https:\/\/doi.org\/10.1038\/nature12394","journal-title":"Nature"},{"key":"2651_CR38","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s42003-021-02242-7","volume":"4","author":"K Kawatani","year":"2021","unstructured":"Kawatani K, Nambara T, Nawa N, Yoshimatsu H, Kusakabe H, Hirata K, Tanave A, Sumiyama K, Banno K, Taniguchi H, Arahori H, Ozono K, Kitabatake Y (2021) A human isogenic iPSC-derived cell line panel identifies major regulators of aberrant astrocyte proliferation in Down syndrome. Commun Biol 4:730. https:\/\/doi.org\/10.1038\/s42003-021-02242-7","journal-title":"Commun Biol"},{"key":"2651_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.tig.2022.12.001","volume":"39","author":"J Khirallah","year":"2023","unstructured":"Khirallah J, Eimbinder M, Li Y, Xu Q (2023) Clinical progress in genome-editing technology and in vivo delivery techniques. Trends Genet 39:208\u2013216. https:\/\/doi.org\/10.1016\/j.tig.2022.12.001","journal-title":"Trends Genet"},{"key":"2651_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1601-5223.1984.tb00097.x","volume":"100","author":"U Kristoffersson","year":"1984","unstructured":"Kristoffersson U, Bergwall B (1984) Partial trisomy 15(q25qter) in two brothers. Hereditas 100:7\u201310. https:\/\/doi.org\/10.1111\/j.1601-5223.1984.tb00097.x","journal-title":"Hereditas"},{"key":"2651_CR41","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.09.574742","author":"JB Lawrence","year":"2024","unstructured":"Lawrence JB, Hall LL, Creamer KM, Byron MF (2024) Differences in Alu vs L1-rich chromosome bands underpin architectural reorganization of the inactive-X chromosome and SAHFs. bioRxiv. https:\/\/doi.org\/10.1101\/2024.01.09.574742","journal-title":"bioRxiv"},{"key":"2651_CR42","first-page":"441","volume":"27","author":"JT Leisti","year":"1975","unstructured":"Leisti JT, Kaback MM, Rimoin DL (1975) Human X-autosome translocations: differential inactivation of the X chromosome in a kindred with an X-9 translocation. Am J Hum Genet 27:441\u2013453","journal-title":"Am J Hum Genet"},{"key":"2651_CR43","doi-asserted-by":"publisher","DOI":"10.3791\/56398","author":"V Leko","year":"2018","unstructured":"Leko V, Sripathy S, Adrianse RL, Loe T, Park A, Lao U, Foss EJ, Bartolomei MS, Bedalov A (2018) Pooled shRNA screen for reactivation of MeCP2 on the inactive X chromosome. J vis Exp. https:\/\/doi.org\/10.3791\/56398","journal-title":"J vis Exp"},{"key":"2651_CR44","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","volume":"25","author":"CA Lino","year":"2018","unstructured":"Lino CA, Harper JC, Carney JP, Timlin JA (2018) Delivering CRISPR: a review of the challenges and approaches. Drug Deliv 25:1234\u20131257. https:\/\/doi.org\/10.1080\/10717544.2018.1474964","journal-title":"Drug Deliv"},{"key":"2651_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008333","volume":"15","author":"A Loda","year":"2019","unstructured":"Loda A, Heard E (2019) Xist RNA in action: past, present, and future. PLoS Genet 15:e1008333. https:\/\/doi.org\/10.1371\/journal.pgen.1008333","journal-title":"PLoS Genet"},{"key":"2651_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41580-021-00438-7","volume":"23","author":"A Loda","year":"2022","unstructured":"Loda A, Collombet S, Heard E (2022) Gene regulation in time and space during X-chromosome inactivation. Nat Rev Mol Cell Biol 23:231\u2013249. https:\/\/doi.org\/10.1038\/s41580-021-00438-7","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2651_CR47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1523\/JNEUROSCI.4445-12.2013","volume":"33","author":"S Malik","year":"2013","unstructured":"Malik S, Vinukonda G, Vose LR, Diamond D, Bhimavarapu BB, Hu F, Zia MT, Hevner R, Zecevic N, Ballabh P (2013) Neurogenesis continues in the third trimester of pregnancy and is suppressed by premature birth. J Neurosci 33:411\u2013423. https:\/\/doi.org\/10.1523\/JNEUROSCI.4445-12.2013","journal-title":"J Neurosci"},{"key":"2651_CR48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF00276593","volume":"61","author":"MG Mattei","year":"1982","unstructured":"Mattei MG, Mattei JF, Ayme S, Giraud F (1982) X-autosome translocations: cytogenetic characteristics and their consequences. Hum Genet 61:295\u2013309. https:\/\/doi.org\/10.1007\/BF00276593","journal-title":"Hum Genet"},{"key":"2651_CR49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1101\/gr.4627606","volume":"16","author":"JA McNeil","year":"2006","unstructured":"McNeil JA, Smith KP, Hall LL, Lawrence JB (2006) Word frequency analysis reveals enrichment of dinucleotide repeats on the human X chromosome and [GATA]n in the X escape region. Genome Res 16:477\u2013484. https:\/\/doi.org\/10.1101\/gr.4627606","journal-title":"Genome Res"},{"key":"2651_CR50","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/s41436-020-0779-4","volume":"22","author":"BR Migeon","year":"2020","unstructured":"Migeon BR (2020) X-linked diseases: susceptible females. Genet Med 22:1156\u20131174. https:\/\/doi.org\/10.1038\/s41436-020-0779-4","journal-title":"Genet Med"},{"key":"2651_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111174","volume":"40","author":"JE Moon","year":"2022","unstructured":"Moon JE, Lawrence JB (2022) Chromosome silencing in vitro reveals trisomy 21 causes cell-autonomous deficits in angiogenesis and early dysregulation in Notch signaling. Cell Rep 40:111174. https:\/\/doi.org\/10.1016\/j.celrep.2022.111174","journal-title":"Cell Rep"},{"key":"2651_CR52","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","volume":"21","author":"RA Morgan","year":"2017","unstructured":"Morgan RA, Gray D, Lomova A, Kohn DB (2017) Hematopoietic stem cell gene therapy: progress and lessons learned. Cell Stem Cell 21:574\u2013590. https:\/\/doi.org\/10.1016\/j.stem.2017.10.010","journal-title":"Cell Stem Cell"},{"key":"2651_CR53","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/hmg\/ddac285","volume":"32","author":"MJ Navarro-Cobos","year":"2023","unstructured":"Navarro-Cobos MJ, Morales-Guzman SI, Baldry SEL, Brown CJ (2023) Derivation of a minimal functional XIST by combining human and mouse interaction domains. Hum Mol Genet 32:1289\u20131300. https:\/\/doi.org\/10.1093\/hmg\/ddac285","journal-title":"Hum Mol Genet"},{"key":"2651_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0092-8674(94)90233-x","volume":"77","author":"DP Norris","year":"1994","unstructured":"Norris DP, Patel D, Kay GF, Penny GD, Brockdorff N, Sheardown SA, Rastan S (1994) Evidence that random and imprinted Xist expression is controlled by preemptive methylation. Cell 77:41\u201351. https:\/\/doi.org\/10.1016\/0092-8674(94)90233-x","journal-title":"Cell"},{"key":"2651_CR55","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.neuron.2016.01.042","volume":"89","author":"JL Olmos-Serrano","year":"2016","unstructured":"Olmos-Serrano JL, Kang HJ, Tyler WA, Silbereis JC, Cheng F, Zhu Y, Pletikos M, Jankovic-Rapan L, Cramer NP, Galdzicki Z, Goodliffe J, Peters A, Sethares C, Delalle I, Golden JA, Haydar TF, Sestan N (2016) Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination. Neuron 89:1208\u20131222. https:\/\/doi.org\/10.1016\/j.neuron.2016.01.042","journal-title":"Neuron"},{"key":"2651_CR56","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1399-0004.1976.tb01591.x","volume":"9","author":"C Pedersen","year":"1976","unstructured":"Pedersen C (1976) Letter: partial trisomy 15 as a result of an unbalanced 12\/15 translocation in a patient with a cloverleaf skull anomaly. Clin Genet 9:378\u2013380","journal-title":"Clin Genet"},{"issue":"955\u2013969","key":"2651_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2017.11.013","volume":"68","author":"G Pintacuda","year":"2017","unstructured":"Pintacuda G, Wei G, Roustan C, Kirmizitas BA, Solcan N, Cerase A, Castello A, Mohammed S, Moindrot B, Nesterova TB, Brockdorff N (2017) hnRNPK recruits PCGF3\/5-PRC1 to the Xist RNA B-repeat to establish polycomb-mediated chromosomal silencing. Mol Cell 68(955\u2013969):e10. https:\/\/doi.org\/10.1016\/j.molcel.2017.11.013","journal-title":"Mol Cell"},{"key":"2651_CR58","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/ajmg.c.31530","volume":"172","author":"K Plona","year":"2016","unstructured":"Plona K, Kim T, Halloran K, Wynshaw-Boris A (2016) Chromosome therapy: Potential strategies for the correction of severe chromosome aberrations. Am J Med Genet C Semin Med Genet 172:422\u2013430. https:\/\/doi.org\/10.1002\/ajmg.c.31530","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2651_CR59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fcell.2019.00241","volume":"7","author":"BJ Posynick","year":"2019","unstructured":"Posynick BJ, Brown CJ (2019) Escape from X-chromosome inactivation: an evolutionary perspective. Front Cell Dev Biol 7:241. https:\/\/doi.org\/10.3389\/fcell.2019.00241","journal-title":"Front Cell Dev Biol"},{"key":"2651_CR60","doi-asserted-by":"publisher","first-page":"7991","DOI":"10.1073\/pnas.1803792115","volume":"115","author":"P Przanowski","year":"2018","unstructured":"Przanowski P, Wasko U, Zheng Z, Yu J, Sherman R, Zhu LJ, McConnell MJ, Tushir-Singh J, Green MR, Bhatnagar S (2018) Pharmacological reactivation of inactive X-linked Mecp2 in cerebral cortical neurons of living mice. Proc Natl Acad Sci USA 115:7991\u20137996. https:\/\/doi.org\/10.1073\/pnas.1803792115","journal-title":"Proc Natl Acad Sci USA"},{"key":"2651_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add4666","author":"J Qian","year":"2023","unstructured":"Qian J, Guan X, Xie B, Xu C, Niu J, Tang X, Li CH, Colecraft HM, Jaenisch R, Liu XS (2023) Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.add4666","journal-title":"Sci Transl Med"},{"key":"2651_CR100","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1101\/gad.295907.117","volume":"31","author":"R Ridings-Figueroa","year":"2017","unstructured":"Ridings-Figueroa R, Stewart ER, Nesterova TB, Coker H, Pintacuda G, Godwin J, Wilson R, Haslam A, Lilley F, Ruigrok R, Bageghni SA, Albadrani G, Mansfield W, Roulson JA, Brockdorff N, Ainscough JFX, Coverley D (2017) The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory. Genes Dev 31:876\u2013888. https:\/\/doi.org\/10.1101\/gad.295907.117","journal-title":"Genes Dev"},{"key":"2651_CR62","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1042\/BST20210253","volume":"49","author":"AC Raposo","year":"2021","unstructured":"Raposo AC, Casanova M, Gendrel AV, da Rocha ST (2021) The tandem repeat modules of Xist lncRNA: a swiss army knife for the control of X-chromosome inactivation. Biochem Soc Trans 49:2549\u20132560. https:\/\/doi.org\/10.1042\/BST20210253","journal-title":"Biochem Soc Trans"},{"key":"2651_CR63","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/nsmb.1877","volume":"17","author":"ME Royce-Tolland","year":"2010","unstructured":"Royce-Tolland ME, Andersen AA, Koyfman HR, Talbot DJ, Wutz A, Tonks ID, Kay GF, Panning B (2010) The a-repeat links ASF\/SF2-dependent Xist RNA processing with random choice during X inactivation. Nat Struct Mol Biol 17:948\u2013954. https:\/\/doi.org\/10.1038\/nsmb.1877","journal-title":"Nat Struct Mol Biol"},{"key":"2651_CR64","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-021-03191-1","volume":"592","author":"K Saha","year":"2021","unstructured":"Saha K, Sontheimer EJ, Brooks PJ, Dwinell MR, Gersbach CA, Liu DR, Murray SA, Tsai SQ, Wilson RC, Anderson DG, Asokan A, Banfield JF, Bankiewicz KS, Bao G, Bulte JWM, Bursac N, Campbell JM, Carlson DF, Chaikof EL, Chen ZY, Cheng RH, Clark KJ, Curiel DT, Dahlman JE, Deverman BE, Dickinson ME, Doudna JA, Ekker SC, Emborg ME, Feng G, Freedman BS, Gamm DM, Gao G, Ghiran IC, Glazer PM, Gong S, Heaney JD, Hennebold JD, Hinson JT, Khvorova A, Kiani S, Lagor WR, Lam KS, Leong KW, Levine JE, Lewis JA, Lutz CM, Ly DH, Maragh S, McCray PB Jr, McDevitt TC, Mirochnitchenko O, Morizane R, Murthy N, Prather RS, Ronald JA, Roy S, Roy S, Sabbisetti V, Saltzman WM, Santangelo PJ, Segal DJ, Shimoyama M, Skala MC, Tarantal AF, Tilton JC, Truskey GA, Vandsburger M, Watts JK, Wells KD, Wolfe SA, Xu Q, Xue W, Yi G, Zhou J, Consortium S (2021) The NIH somatic cell genome editing program. Nature 592:195\u2013204. https:\/\/doi.org\/10.1038\/s41586-021-03191-1","journal-title":"Nature"},{"key":"2651_CR65","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.1128\/MCB.00810-06","volume":"26","author":"F Savarese","year":"2006","unstructured":"Savarese F, Flahndorfer K, Jaenisch R, Busslinger M, Wutz A (2006) Hematopoietic precursor cells transiently reestablish permissiveness for X inactivation. Mol Cell Biol 26:7167\u20137177. https:\/\/doi.org\/10.1128\/MCB.00810-06","journal-title":"Mol Cell Biol"},{"key":"2651_CR66","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/ajmg.1320420205","volume":"42","author":"M Schmidt","year":"1992","unstructured":"Schmidt M, Du Sart D (1992) Functional disomies of the X chromosome influence the cell selection and hence the X inactivation pattern in females with balanced X-autosome translocations: a review of 122 cases. Am J Med Genet 42:161\u2013169. https:\/\/doi.org\/10.1002\/ajmg.1320420205","journal-title":"Am J Med Genet"},{"key":"2651_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13073-017-0411-7","volume":"9","author":"RR Shah","year":"2017","unstructured":"Shah RR, Bird AP (2017) MeCP2 mutations: progress towards understanding and treating Rett syndrome. Genome Med 9:17. https:\/\/doi.org\/10.1186\/s13073-017-0411-7","journal-title":"Genome Med"},{"key":"2651_CR68","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ajmg.a.31096","volume":"140","author":"P Stankiewicz","year":"2006","unstructured":"Stankiewicz P, Kuechler A, Eller CD, Sahoo T, Baldermann C, Lieser U, Hesse M, Glaser C, Hagemann M, Yatsenko SA, Liehr T, Horsthemke B, Claussen U, Marahrens Y, Lupski JR, Hansmann I (2006) Minimal phenotype in a girl with trisomy 15q due to t(X;15)(q22.3;q11.2) translocation. Am J Med Genet A 140:442\u2013452. https:\/\/doi.org\/10.1002\/ajmg.a.31096","journal-title":"Am J Med Genet A"},{"key":"2651_CR69","first-page":"219","volume":"14","author":"RL Summitt","year":"1978","unstructured":"Summitt RL, Tipton RE, Wilroy RS Jr, Martens PR, Phelan JP (1978) X-autosome translocations: a review. Birth Defects Orig Artic Ser 14:219\u2013247","journal-title":"Birth Defects Orig Artic Ser"},{"key":"2651_CR70","doi-asserted-by":"publisher","first-page":"10654","DOI":"10.1073\/pnas.1711206114","volume":"114","author":"H Sunwoo","year":"2017","unstructured":"Sunwoo H, Colognori D, Froberg JE, Jeon Y, Lee JT (2017) Repeat E anchors Xist RNA to the inactive X chromosomal compartment through CDKN1A-interacting protein (CIZ1). Proc Natl Acad Sci USA 114:10654\u201310659. https:\/\/doi.org\/10.1073\/pnas.1711206114","journal-title":"Proc Natl Acad Sci USA"},{"key":"2651_CR71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1172-5-8","volume":"5","author":"NR Tartaglia","year":"2010","unstructured":"Tartaglia NR, Howell S, Sutherland A, Wilson R, Wilson L (2010) A review of trisomy X (47, XXX). Orphanet J Rare Dis 5:8. https:\/\/doi.org\/10.1186\/1750-1172-5-8","journal-title":"Orphanet J Rare Dis"},{"key":"2651_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112686","volume":"42","author":"M Valledor","year":"2023","unstructured":"Valledor M, Byron M, Dumas B, Carone DM, Hall LL, Lawrence JB (2023) Early chromosome condensation by XIST builds a-repeat RNA density that facilitates gene silencing. Cell Rep 42:112686. https:\/\/doi.org\/10.1016\/j.celrep.2023.112686","journal-title":"Cell Rep"},{"key":"2651_CR73","doi-asserted-by":"publisher","first-page":"E2029","DOI":"10.1073\/pnas.1520113113","volume":"113","author":"J Wang","year":"2016","unstructured":"Wang J, Syrett CM, Kramer MC, Basu A, Atchison ML, Anguera MC (2016) Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X. Proc Natl Acad Sci USA 113:E2029\u2013E2038. https:\/\/doi.org\/10.1073\/pnas.1520113113","journal-title":"Proc Natl Acad Sci USA"},{"key":"2651_CR74","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PWL, Gao G (2019) Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov 18:358\u2013378. https:\/\/doi.org\/10.1038\/s41573-019-0012-9","journal-title":"Nat Rev Drug Discov"},{"key":"2651_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.645647","volume":"9","author":"W Wang","year":"2021","unstructured":"Wang W, Min L, Qiu X, Wu X, Liu C, Ma J, Zhang D, Zhu L (2021) Biological function of long non-coding RNA (LncRNA) Xist. Front Cell Dev Biol 9:645647. https:\/\/doi.org\/10.3389\/fcell.2021.645647","journal-title":"Front Cell Dev Biol"},{"key":"2651_CR76","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41588-023-01399-7","volume":"55","author":"KA Waugh","year":"2023","unstructured":"Waugh KA, Minter R, Baxter J, Chi C, Galbraith MD, Tuttle KD, Eduthan NP, Kinning KT, Andrysik Z, Araya P, Dougherty H, Dunn LN, Ludwig M, Schade KA, Tracy D, Smith KP, Granrath RE, Busquet N, Khanal S, Anderson RD, Cox LL, Estrada BE, Rachubinski AL, Lyford HR, Britton EC, Fantauzzo KA, Orlicky DJ, Matsuda JL, Song K, Cox TC, Sullivan KD, Espinosa JM (2023) Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model. Nat Genet 55:1034\u20131047. https:\/\/doi.org\/10.1038\/s41588-023-01399-7","journal-title":"Nat Genet"},{"key":"2651_CR77","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/s1097-2765(00)80248-8","volume":"5","author":"A Wutz","year":"2000","unstructured":"Wutz A, Jaenisch R (2000) A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation. Mol Cell 5:695\u2013705. https:\/\/doi.org\/10.1016\/s1097-2765(00)80248-8","journal-title":"Mol Cell"},{"key":"2651_CR78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/ng820","volume":"30","author":"A Wutz","year":"2002","unstructured":"Wutz A, Rasmussen TP, Jaenisch R (2002) Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nat Genet 30:167\u2013174. https:\/\/doi.org\/10.1038\/ng820","journal-title":"Nat Genet"},{"issue":"1790\u20131803","key":"2651_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.02.015","volume":"184","author":"B Yu","year":"2021","unstructured":"Yu B, Qi Y, Li R, Shi Q, Satpathy AT, Chang HY (2021) B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells. Cell 184(1790\u20131803):e17. https:\/\/doi.org\/10.1016\/j.cell.2021.02.015","journal-title":"Cell"},{"key":"2651_CR80","doi-asserted-by":"publisher","first-page":"398","DOI":"10.14336\/AD.2022.00725","volume":"14","author":"J Yu","year":"2023","unstructured":"Yu J, Li T, Zhu J (2023) Gene therapy strategies targeting aging-related diseases. Aging Dis 14:398\u2013417. https:\/\/doi.org\/10.14336\/AD.2022.00725","journal-title":"Aging Dis"},{"key":"2651_CR81","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1039\/d2tb01179d","volume":"11","author":"L Zhu","year":"2023","unstructured":"Zhu L, Luo J, Ren K (2023) Nucleic acid-based artificial nanocarriers for gene therapy. J Mater Chem B 11:261\u2013279. https:\/\/doi.org\/10.1039\/d2tb01179d","journal-title":"J Mater Chem B"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-024-02651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00439-024-02651-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-024-02651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T02:02:38Z","timestamp":1722564158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00439-024-02651-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,9]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2651"],"URL":"https:\/\/doi.org\/10.1007\/s00439-024-02651-8","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,9]]},"assertion":[{"value":"10 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}